Apogee Therapeutics, Inc. APGE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$274.62M-7.3% | -$255.84M-0.9% | -$253.67M-6.7% | -$237.67M-15.7% | -$205.39M-12.8% | ||
| $1.61M+14.2% | $1.41M+30.5% | $1.08M+48.2% | $731K+99.2% | $367K+94.2% | ||
| $52.31M+13.0% | $46.28M+10.3% | $41.96M+16.8% | $35.92M+18.7% | $30.27M+29.7% | ||
| -$234.54M-3.1% | -$227.45M+2.2% | -$232.48M-5.3% | -$220.74M-17.4% | -$188.02M-9.8% | ||
| —— | $5.15M+1.2% | $5.09M-12.9% | $5.84M+14.0% | $5.12M+344% | ||
| -$227.91M-26.9% | -$179.57M— | —— | —— | —— | ||
| $807.04M+104% | $396.49M+502% | $65.9M+41.6% | $46.54M+2.6% | $45.36M-90.8% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Apogee Therapeutics, Inc. generate?
- Apogee Therapeutics, Inc. (APGE) generated -$234.5M in operating cash flow over the trailing twelve months.
- What is Apogee Therapeutics, Inc.'s free cash flow?
- After $5.1M of capital expenditures, Apogee Therapeutics, Inc.'s free cash flow was -$232.6M over the trailing twelve months, down 35.0% year over year.
- Where does Apogee Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.